Cancer Archive — Page 5 of 70

Anna Means, PhD, R. Daniel Beauchamp, MD, and colleagues are studying a group of proteins that are essential to the growth of colorectal cancer tumors.
December 8, 2025

Vanderbilt research community mourns loss of longtime colleague Anna Means

In addition to her research, Dr. Means mentored dozens of undergraduate, graduate and postdoctoral students, research staff and faculty.

(iStock image)
December 8, 2025

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

(photo by Erin O. Smith)
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

(iStock)
December 2, 2025

Women who receive mammograms also undergo lung scans if notified of eligibility

Study showed that the improvement in lung cancer screenings exceeded the target enrollment set by the researchers.

(photo by Erin O. Smith)
November 4, 2025

Becker’s Hospital Review recognizes VUMC as a top oncology provider  

Vanderbilt-Ingram Cancer Center serves more than 49,000 distinct patients and manages over 250,000 outpatient visits annually.